Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Sorafenib and Zoledronic Acid in Advanced HCC

NCT01259193 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT01259193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01259193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Sorafenib and Zoledronic Acid in Advanced HCC
Lead sponsor
Fudan University
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2010
Completion date
July 31, 2012
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma